EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS

EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS

Objective. To evaluate the efficacy, tolerability and safety of the drug Diacerein (Artrocker) in patients with osteoarthritis (OA) of the hip joints after continuous administration for 4 months and the duration of the drug effects for 2 months. Materials and methods. The study included 30 patients...

Full description

Bibliographic Details
Main Authors:	E. P. Sharapova, N. G. Kashevarova, E. M. Zaytseva, S. G. Anikin, T. A. Korotkova, L. I. L.I. Alexeeva
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-12-01
Series:	Медицинский совет
Subjects:	osteoarthritis, pain diacerein clinical efficacy tolerability adverse events
Online Access:	https://www.med-sovet.pro/jour/article/view/1666

Similar Items

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Diacerein the treatment of osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2016-12-01)

NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME
by: L. I. Alexeeva, et al.
Published: (2018-02-01)

Diacerein, its beneficial impact on chondrocytes and notable new clinical applications
by: Daljit Kaur, et al.
Published: (2019-04-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01)

KNEE OSTEOARTHRITIS AND METABOLIC SYNDROME: NEW APPROACHES TO THERAPY
by: L. I. Alekseeva, et al.
Published: (2018-05-01)

Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity
by: Frengki Frengki, et al.
Published: (2020-11-01)

Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial
by: Andrei E. Karateev, et al.
Published: (2021-05-01)

Diacerein-Loaded Hyaluosomes as a Dual-Function Platform for Osteoarthritis Management via Intra-Articular Injection: In Vitro Characterization and In Vivo Assessment in a Rat Model
by: Nouran O. Eladawy, et al.
Published: (2021-05-01)

Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes
by: Bibiane Steinecker-Frohnwieser, et al.
Published: (2017-09-01)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
by: Basma Mostafa Zaki, et al.
Published: (2015-09-01)

Comparative study of the efficacy and safety of Chondroguard® during its combined (intra-articular and intramuscular) and intramuscular injection in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2018-06-01)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
by: K. L. C. da Silva, et al.
Published: (2018-05-01)

Diacerein Ameliorates Liver Ischemia Reperfusion Insult in Rats
by: Soad L. Kabil
Published: (2018-08-01)

PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
by: Raju Rameshrao Thenge, et al.
Published: (2017-01-01)

Evaluation of the efficacy and safety of injectable glycosaminoglycan-peptide complex (GPC) in patients with osteoarthritis: a multicenter observational study GLADIOLUS (GPC in the treatment of osteoarthritis: a follow-up study of pain relief and local symptom reduction)
by: L. I. Alekseeva, et al.
Published: (2020-05-01)

Determination of Picogram Levels of Diacerein in a Pharmaceutical Formulation by Flow-Injection Chemiluminescence
by: Gao Suya, et al.
Published: (2017-01-01)

Diacerein: Recent insight into pharmacological activities and molecular pathways
by: Maged Almezgagi, et al.
Published: (2020-11-01)

USE OF DRUGS ARTHRA MSM FORTE AND ARTHRA FOR OSTEOARTHRITIS AND BACK PAINS
by: L. I. Alekseeva, et al.
Published: (2017-05-01)

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
by: Michael Ablinger, et al.
Published: (2018-11-01)

Evaluation of the efficacy, tolerability, and safety of intra-articular hyaluronic acid in patients with knee osteoarthritis
by: S. G. Anikin, et al.
Published: (2017-09-01)

CLINICAL AND SONOGRAPHIC ASSESSMENT OF SYNOVITIS ACTIVITY IN PATIENTS WITH KNEE OSTEOARTHRITIS DURING THERAPY
by: A. V. Petrov, et al.
Published: (2016-02-01)

Anti-Contractile and Anti-Inflammatory Effects of Diacerein on Isolated Mouse Airways Smooth Muscle and Mouse Asthma Model
by: Shunbo Shi, et al.
Published: (2020-09-01)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
by: Miriam Méndez-del Villar, et al.
Published: (2017-02-01)

Corneal pharmacokinetics of the 2% diacerein eye drops between multiple administration and single administration
by: Ke Yang, et al.
Published: (2018-04-01)

THE INFLUENCE OF COMPLEX THERAPY ON THE INFLAMMATORY MARKERS OF PATIENTS WITH SECONDARY OSTEOARTHRITIS
by: I. A. Starodubtseva
Published: (2015-12-01)

Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation
by: Allam AN, et al.
Published: (2017-07-01)

Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice
by: Guangzhe Yu, et al.
Published: (2018-08-01)

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation
by: Diana E. Aziz, et al.
Published: (2018-01-01)

Diacerein protects rats with liver ischemia/reperfusion damage: Down-regulation of TLR4/ NFκ-B signaling pathway
by: Mohamed Abdellah Ibrahim, et al.
Published: (2021-02-01)

Osteoarthrosis or osteoarthritis? A current view of the disease and its treatment
by: Rimma Mikhailovna Balabanova
Published: (2013-10-01)

Osteoarthrosis or osteoarthritis? A current view of the disease and its treatment
by: Rimma Mikhailovna Balabanova
Published: (2013-10-01)

Topiramate Effectiveness as Add-on Therapy in Bulgarian Patients with Drug-resistant Epilepsy
by: Ekaterina Viteva, et al.
Published: (2020-12-01)

Pain type in osteoarthritis. Approaches to treatment
by: R.M. Balabanova
Published: (2014-05-01)